Related Experiment Video
Updated: May 15, 2026

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
A feedback regulation between Kindlin-2 and GLI1 in prostate cancer cells
Jianchao Gao1, Ammad Aslam Khan, Takashi Shimokawa
1Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Health Science Center, #38 Xue Yuan Road, Beijing 100191, China.
Abstract:
Kindlin-2 is engaged in tumor progression. However, the mechanism accounting for Kindlin-2 regulation in tumor cells remained largely unknown. Here, we report a regulatory loop between Kindlin-2 and GLI1, an effector of Hedgehog signaling pathway. We show that Kindlin-2 is transcriptionally downregulated via GLI1 occupancy on the Kindlin-2 promoter. Adversely, we found that Kindlin-2 promotes GLI1 expression through a mechanism involving GSK3β inactivation and is independent of Smoothened. Functionally, knockdown of Kindlin-2 cooperates with cyclopamine, a Smoothened antagonist, to decrease the viability of prostate cancer cells. Taken together, targeting the Kindlin-2-GLI1 feedback loop may facilitate the killing of prostate cancer cells.
Insights
Kindlin-2 regulates prostate cancer progression by forming a feedback loop with GLI1, a key component of the Hedgehog signaling pathway. Targeting this loop may offer new therapeutic strategies for prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Kindlin-2 plays a role in tumor progression.
- The precise regulation of Kindlin-2 in cancer cells is not well understood.
Purpose of the Study:
- To elucidate the regulatory mechanism of Kindlin-2 in tumor cells.
- To investigate the relationship between Kindlin-2 and the Hedgehog signaling pathway effector, GLI1.
Main Methods:
- Investigated the transcriptional regulation of Kindlin-2 by GLI1.
- Examined the effect of Kindlin-2 on GLI1 expression.
- Utilized GSK3β inactivation and Smoothened antagonist (cyclopamine) in prostate cancer cell models.
Main Results:
- Kindlin-2 is transcriptionally downregulated by GLI1 binding to its promoter.
- Kindlin-2 enhances GLI1 expression via GSK3β inactivation, independent of Smoothened.
- Knockdown of Kindlin-2 combined with cyclopamine significantly reduced prostate cancer cell viability.
Conclusions:
- A novel feedback loop exists between Kindlin-2 and GLI1 in prostate cancer.
- This Kindlin-2-GLI1 feedback loop represents a potential therapeutic target for prostate cancer treatment.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Activation and Inactivation of G Proteins
Amplifying Signals via Enzymatic Cascade

